These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27203389)

  • 21. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice.
    Zanesi N; Aqeilan R; Drusco A; Kaou M; Sevignani C; Costinean S; Bortesi L; La Rocca G; Koldovsky P; Volinia S; Mancini R; Calin G; Scott CP; Pekarsky Y; Croce CM
    Cancer Res; 2006 Jan; 66(2):915-20. PubMed ID: 16424025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage.
    Ferrero E; Scabini S; Magni E; Foglieni C; Belloni D; Colombo B; Curnis F; Villa A; Ferrero ME; Corti A
    FASEB J; 2004 Mar; 18(3):554-6. PubMed ID: 14734634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new chromogranin A-dependent angiogenic switch activated by thrombin.
    Crippa L; Bianco M; Colombo B; Gasparri AM; Ferrero E; Loh YP; Curnis F; Corti A
    Blood; 2013 Jan; 121(2):392-402. PubMed ID: 23190532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromogranin A regulates tumor self-seeding and dissemination.
    Dondossola E; Crippa L; Colombo B; Ferrero E; Corti A
    Cancer Res; 2012 Jan; 72(2):449-59. PubMed ID: 22139379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasostatin I (CgA17-76) vasoconstricts rat splanchnic vascular bed but does not affect central cardiovascular function.
    Rahman AA; Shahid IZ; Fong AY; Hammond AM; Pilowsky PM
    Auton Neurosci; 2012 Jan; 166(1-2):22-8. PubMed ID: 21937287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating chromogranin A and its fragments as diagnostic and prognostic disease markers.
    Corti A; Marcucci F; Bachetti T
    Pflugers Arch; 2018 Jan; 470(1):199-210. PubMed ID: 29018988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatiotemporal Regulation of Tumor Angiogenesis by Circulating Chromogranin A Cleavage and Neuropilin-1 Engagement.
    Dallatomasina A; Gasparri AM; Colombo B; Sacchi A; Bianco M; Daniele T; Esposito A; Pastorino F; Ponzoni M; Marcucci F; Curnis F; Corti A
    Cancer Res; 2019 Apr; 79(8):1925-1937. PubMed ID: 30796053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant N-terminal fragments of chromogranin-A modulate cardiac function of the Langendorff-perfused rat heart.
    Cerra MC; De Iuri L; Angelone T; Corti A; Tota B
    Basic Res Cardiol; 2006 Jan; 101(1):43-52. PubMed ID: 16151967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EphrinA4 plays a critical role in α4 and αL mediated survival of human CLL cells during extravasation.
    Flores MA; Fortea P; Trinidad EM; García D; Soler G; Ortuño FJ; Zapata AG; Alonso-Colmenar LM
    Oncotarget; 2016 Jul; 7(30):48481-48500. PubMed ID: 27374180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The vascular endothelial growth factor receptor tyrosine kinase inhibitors vatalanib and pazopanib potently induce apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo.
    Paesler J; Gehrke I; Gandhirajan RK; Filipovich A; Hertweck M; Erdfelder F; Uhrmacher S; Poll-Wolbeck SJ; Hallek M; Kreuzer KA
    Clin Cancer Res; 2010 Jul; 16(13):3390-8. PubMed ID: 20570929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The chromogranin A-derived peptides vasostatin-I and catestatin as regulatory peptides for cardiovascular functions.
    Helle KB
    Cardiovasc Res; 2010 Jan; 85(1):9-16. PubMed ID: 19640932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromogranin A restricts drug penetration and limits the ability of NGR-TNF to enhance chemotherapeutic efficacy.
    Dondossola E; Gasparri AM; Colombo B; Sacchi A; Curnis F; Corti A
    Cancer Res; 2011 Sep; 71(17):5881-90. PubMed ID: 21799030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nutlin-3 downregulates the expression of the oncogene TCL1 in primary B chronic lymphocytic leukemic cells.
    Voltan R; di Iasio MG; Bosco R; Valeri N; Pekarski Y; Tiribelli M; Secchiero P; Zauli G
    Clin Cancer Res; 2011 Sep; 17(17):5649-55. PubMed ID: 21753157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parastatin (porcine chromogranin A347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion.
    Fasciotto BH; Trauss CA; Greeley GH; Cohn DV
    Endocrinology; 1993 Aug; 133(2):461-6. PubMed ID: 8344192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Siglec-6 as a therapeutic target for cell migration and adhesion in chronic lymphocytic leukemia.
    Nunes J; Tafesse R; Mao C; Purcell M; Mo X; Zhang L; Long M; Cyr MG; Rader C; Muthusamy N
    Nat Commun; 2024 Jun; 15(1):5180. PubMed ID: 38890323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
    Mollinedo F; de la Iglesia-Vicente J; Gajate C; Estella-Hermoso de Mendoza A; Villa-Pulgarin JA; de Frias M; Roué G; Gil J; Colomer D; Campanero MA; Blanco-Prieto MJ
    Clin Cancer Res; 2010 Apr; 16(7):2046-54. PubMed ID: 20233887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic lymphocytic leukemia with prostate infiltration mediated by specific clonal membrane-bound IgM.
    Bogdan CA; Alexander AA; Gorny MK; Matute R; Marjanovic N; Zolla-Pazner S; Walden PD; Furneaux HM; Sidhu GS; Jacobson DR
    Cancer Res; 2003 May; 63(9):2067-71. PubMed ID: 12727821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and regulation of COP1 in chronic lymphocytic leukemia cells for promotion of cell proliferation and tumorigenicity.
    Fu C; Gong Y; Shi X; Shi H; Wan Y; Wu Q; Xu K
    Oncol Rep; 2016 Mar; 35(3):1493-500. PubMed ID: 26717976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.